Detalhe da pesquisa
1.
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience.
Int J Gynecol Cancer
; 33(4): 514-520, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746489
2.
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.
Int J Gynecol Cancer
; 33(6): 922-928, 2023 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759000
3.
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Br J Cancer
; 127(8): 1479-1486, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869143
4.
Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33).
Int J Gynecol Cancer
; 31(10): 1369-1373, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607820
5.
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Gynecol Oncol
; 156(1): 38-44, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31699415
6.
Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study.
Int J Gynecol Cancer
; 28(4): 684-691, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29489475
7.
New adverse obstetrics outcomes associated with endometriosis: a retrospective cohort study.
Arch Gynecol Obstet
; 295(1): 141-151, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27770245
8.
Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives.
Expert Rev Anticancer Ther
; : 1-7, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38861580
9.
Recent progress in the use of pharmacotherapy for endometrial cancer.
Expert Opin Pharmacother
; 24(1): 83-94, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35912837
10.
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.
Cancer Manag Res
; 15: 1063-1072, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790898
11.
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives.
Front Oncol
; 12: 831612, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35280728
12.
PARP Inhibitors Resistance: Mechanisms and Perspectives.
Cancers (Basel)
; 14(6)2022 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326571
13.
Advanced and recurrent endometrial cancer: State of the art and future perspectives.
Crit Rev Oncol Hematol
; 180: 103851, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257537
14.
Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: A literature review.
Crit Rev Oncol Hematol
; 168: 103542, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34801701
15.
Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine.
Gynecol Oncol Rep
; 32: 100547, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128357
16.
New medical approaches in advanced ovarian cancer.
Minerva Med
; 110(4): 367-384, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31124637
17.
Severe Fetal Distress and Placental Damage might be Associated with High Troponin I (cTnI) Levels in Mothers.
Am J Case Rep
; 19: 194-198, 2018 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463784
18.
Spontaneous Resolution of an Acquired Uterine Arteriovenous Malformation in an Elderly Primigravida.
Am J Case Rep
; 19: 1140-1145, 2018 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30258044
19.
Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients.
Biomed Res Int
; 2018: 1618056, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29808163
20.
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer.
PLoS One
; 13(4): e0195877, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29698418